Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

X

Milena Izmirlieva

10 Aug 2021

Pricing and Market Access

Delta variant prompts change in policy responses

10 Aug 2021

16 Jun 2021

Pricing and Market Access

Reimbursement outcomes for combination therapies in breast cancer

16 Jun 2021

16 Apr 2021

Pricing and Market Access

Vaccine hesitancy boosts risks from vaccine nationalism

16 Apr 2021

27 Jul 2020

Pricing and Market Access

Trump resurrects International Reference Pricing (IRP) proposal on pharmaceuticals with executive order

27 Jul 2020

19 Mar 2020

Pricing and Market Access

COVID-19 pandemic: Health system surge capacity

19 Mar 2020

02 Dec 2019

Pricing and Market Access

Risks to UK pharmaceutical spending from a US-UK free trade deal

02 Dec 2019

04 Nov 2019

Pricing and Market Access

Challenges with risk sharing in Eastern Europe raised at ISPOR Europe meeting

04 Nov 2019

12 Feb 2019

Pricing and Market Access

United States experience dramatic shift in public share of healthcare spending

12 Feb 2019

14 Nov 2018

Pricing and Market Access

Our pricing and reimbursement research presented at ISPOR Europe

14 Nov 2018

04 Dec 2017

Pricing and Market Access

National Academies report adds fuel to fire in raging US drug pricing debates

04 Dec 2017